Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-165X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis ; day:22 ; month:11 ; year:2019 ; pages:1-11
European child & adolescent psychiatry ; (22.11.2019), 1-11
- Creator
-
Arango, Celso
Ng-Mak, Daisy
Finn, Elaine
Byrne, Aidan
Loebel, Antony
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00787-019-01425-2
- URN
-
urn:nbn:de:101:1-2020032614280733990846
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Arango, Celso
- Ng-Mak, Daisy
- Finn, Elaine
- Byrne, Aidan
- Loebel, Antony
- SpringerLink (Online service)
Other Objects (12)
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia
Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects
Association between Ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Atypical course in severe catatonic schizophrenia in a cannabis-dependent male adolescent: a case report
One-Year Medication Treatment Patterns, Healthcare Resource Utilization, and Expenditures for Medicaid Patients with Schizophrenia Starting Oral Atypical Antipsychotic Medication
Atypical antipsychotic agents; Peas in a pod or chalk and cheese?
Unlocking treatment success: predicting atypical antipsychotic continuation in youth with mania
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia
Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects
Association between Ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Atypical course in severe catatonic schizophrenia in a cannabis-dependent male adolescent: a case report
One-Year Medication Treatment Patterns, Healthcare Resource Utilization, and Expenditures for Medicaid Patients with Schizophrenia Starting Oral Atypical Antipsychotic Medication
Atypical antipsychotic agents; Peas in a pod or chalk and cheese?
Unlocking treatment success: predicting atypical antipsychotic continuation in youth with mania
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia
Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects
Association between Ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Atypical course in severe catatonic schizophrenia in a cannabis-dependent male adolescent: a case report
One-Year Medication Treatment Patterns, Healthcare Resource Utilization, and Expenditures for Medicaid Patients with Schizophrenia Starting Oral Atypical Antipsychotic Medication
Atypical antipsychotic agents; Peas in a pod or chalk and cheese?
Unlocking treatment success: predicting atypical antipsychotic continuation in youth with mania
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia